Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features

Abedin, Sameem ; Guru Murthy, Guru Subramanian ; Szabo, Aniko ; Hamadani, Mehdi ; Michaelis, Laura C. ; Carlson, Karen-Sue ; Runaas, Lyndsey ; Gauger, Katelyn ; Desai, Avinash G ; Chen, Mary M ; Harrington, Alexandra M. ; Atallah, Ehab L.

Blood, 2022-11, Vol.140 (Supplement 1), p.157-158 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível